National Health (Listed drugs on F1 or F2) Amendment Determination 2014 (No. 3) (No. PB 32 of 2014) (Cth)

PB 32 of 2014

National Health (Listed drugs on F1 or F2) Amendment Determination 2014 (No. 3)

National Health Act 1953

I, ADRIANA PLATONA, Assistant Secretary, Pharmaceutical Evaluation Branch, Pharmaceutical Benefits Division, Department of Health, delegate of the Minister for Health, make this determination under subsection 85AB(1) of the National Health Act 1953.

Dated           11                April 2014

ADRIANA PLATONA

Assistant Secretary

Pharmaceutical Evaluation Branch

Pharmaceutical Benefits Division

Department of Health

Part 1         Preliminary

1. Name of Determination

(1)   This Determination is the National Health (Listed drugs on F1 or F2) Amendment Determination 2014 (No. 3).

(2)   This Determination may also be cited as PB 32 of 2014.

1. Commencement

This Determination commences on 1 May 2014.

1. Amendment of National Health (Listed drugs on F1 or F2) Determination 2010

Schedule 1 amends the National Health (Listed drugs on F1 or F2) Determination 2010 (PB 93 of 2010).

Schedule 1             Amendments

(Section 3)

[1]     Schedule 1, after item dealing with Amylopectin, modified long chain

Omit

Anakinra

[2]     Schedule 1, after item dealing with Methylnaltrexone

Omit

Methysergide

[3]     Schedule 1, after item dealing with Penicillamine

Omit

Pergolide

[4]     Schedule 1, after item dealing with Pizotifen

Insert

Plerixafor

[5]     Schedule 1, after item dealing with Salmeterol

Insert

Sapropterin